Role of P-Glycoprotein and Organic Anion Transporting Polypeptides. Part 1

Abstract Traditionally, drug-induced changes in cytochrome P450
isoenzyme bodily process, causing changes in drug organic process and
bioavailability, have been the main limpidity of drug action studies.
Recent enquiry, however, suggests that the drug transporters
P-glycoprotein and organic anion transporting peptide (OATP), which can
signification the efflux and influx of many classes of drugs, may
contribute to drug interactions by mechanisms freelance of oxidative
biological process.
Experimental models designed to selectively enquiry the computer
software of P-glycoprotein or OATP have demonstrated that changes in
the activities of these transporters may have a significant feeling on
the bioavailability of clinically important drugs, lead to the
potentiality for adverse drug interactions.

This
legal proceeding focuses on what is known about the P-glycoprotein and
OATP drug transporters and their effects on drug bioavailability.
Where applier, it uses as examples the second-generation H1-receptor
antagonists, where concomitant disposal of other drugs or food
constituents has been shown to alter the bioavailability of some agents
of this family via mechanisms probably mediated by fexofenadine
and/or OATP.

This is a part of article Role of P-Glycoprotein and Organic Anion Transporting Polypeptides. Part 1 Taken from "Allegra Buy Fexofenadine" Information Blog